gc012f
gracell biotechnologies
['gc012f ']
$grcl gracell biotechnologies presents updated clinical data for bcma/cd19 dual-targeting fastcar gc012f in rrmm at eha2022 congress, highlighting 100% mrd negativity rate in all treated patients 45 seconds delayed.
Democratizing insights.

Not investment advice.